Comprehensive CDMO solutions from preclinical to commercial
We focus on addressing our clients' most critical and complex drug discovery and development challenges. With our specialized knowledge, technical expertise, and highly reputed quality of service, we are indispensable in transforming our services into solutions tailored to your needs from pre-clinical and commercial analytical development to process development, manufacturing, and quality control.
Our oligonucleotide drug discovery platform is equipped with experienced scientists and state-of-the-art facilities to support your discovery synthesis of oligonucleotides, complex conjugates, monomers, ligands and linkers, from sequence design to Pre-Clinical Candidate (PCC).
Based on our best-view platform, Veliter’s Process Development offers industry-leading development services to solutions tailored to individual customer needs, from the lab to validation and commercial manufacture. Our experts team will ensure our approaches are aligned with regulatory guidelines and GMP industry best practices.
We provide industry-leading sgRNA for gene editing, including pre-clinical production, clinical production and commercialization, and support the development of various in vivo/in vitro gene editing drugs. We are the best GMP sgRNA partner in the world.
Veliter has a dedicated analytical team with extensive experience and expertise in oligonucleotide analysis across all development phases from pre-clinical development to commercial manufacturing, covering both drug substance and drug product.
We provide a one-stop solution for complex oligonucleotide-base conjugated drugs, from discovery through development to commercial manufacturing.Supported by a wealth of experience, we offer flexible options with rapid turnaround time and comprehensive support for design and synthesis with analytical processes at any scale.
Our Awards
Positive oligo program experience, from end to end events
